Trial Profile
Dexmedetomidine versus propofol in awake implantation of a neuromodulative system. (Dexmedetomidine versus propofol tijdens de implantatie van een neuromodulatief systeem).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2020
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Propofol
- Indications Sedation
- Focus Therapeutic Use
- Acronyms DexMedPro
- 03 Dec 2017 Status changed from active, no longer recruiting to completed.
- 08 Oct 2015 New trial record